A peptide is a short chain of amino acids, the same building blocks that form larger proteins. The human body produces millions of them, using them to carry messages, control hormones, regulate ...

The FDA's Pharmacy Compounding Advisory Committee weighs peptides for obesity, insulin resistance, opioid withdrawal and ...

In a scientific review posted ahead of the meeting, FDA scientists reiterated their longstanding concerns. Again and again, ...

People living with early Alzheimer’s disease can now begin treatment with Leqembi without setting foot in an infusion center.

When Sanofi won FDA approval in July 2026 for the first anticancer treatment administered with an on-body injector (OBI), the Enable Injections enFuse platform made it possible. The enFuse OBI secured ...

Temporary Suspension of KOSPI Transfer Listing...Background of Staying Attracts Attention While Alteogen has faced share ...

With concerns over the competitiveness of its subcutaneous (SC) injection platform leading to a sharp decline in its stock ...

Agreement provides Incyte the rights to develop and commercialize ENHANZE® with its mutCALR development program and an option to nominate up to two additional targets ...

Halozyme Therapeutics, Inc. ("Halozyme" or the "Company") today announced that it has entered into a global collaboration and license agreement with Incyte to evaluate additional subcutaneous ...

Joseph Mikhael, MD, MEd, highlights the clinical and logistical advantages of the novel on-body injector developed for the ...

We analyzed 10 online NAD+ platforms and outlined the crucial characteristics for you. Take a look at the platforms that ...

Patients in the US are to have easier initial access to a new drug to treat Alzheimer’s disease thanks to a decision by the ...